S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Haemonetics to Present at the 33rd Annual J.P. Morgan Health Care Conference (2014/12/22)|
|Due To Winter Storm, Haemonetics Moves Announcement of Third Quarter Fiscal 2015 Earnings Results To Thursday, January 29 (2015/1/26)|
|Haemonetics Sets Date for Third Quarter Fiscal Year 2015 Earnings Release: January 28, 2015 (2014/12/29)|
|Haemonetics to Present at the Raymond James 36th Annual Institutional Investors Conference (2015/2/25)|
|Haemonetics Reports 3rd Quarter Fiscal 2015 Revenue of $232 Million and Adjusted EPS of $0.53; Reaffirms Revenue and EPS Guidance (2015/1/29)|
|FDA Grants Fast Track Designation for BCX4161 for the Treatment of Hereditary Angioedema (2015/1/26)|
|BioCryst Initiates OPuS-2: A Clinical Trial of BCX4161 in Patients With Hereditary Angioedema (2014/12/18)|
|Pharming and Salix Announce First Patient Treated in Clinical Study of Ruconest® for Prophylaxis of Hereditary Angioedema (2015/1/8)|
|BioCryst Reports Fourth Quarter & Full Year 2014 Financial Results (2015/2/18)|
|BioCryst Receives Positive Opinion on European Orphan Drug Designation for BCX4161 for the Treatment of Hereditary Angioedema (2015/1/14)|
Click above to view more mutual fund data and stats for hae - Haemonetics Corp.